Life Sciences Tools & Services Companies By Pe Ratio

Price To Earning
Price To EarningEfficiencyMarket RiskExp Return
1MLAB Mesa Laboratories
433.94
(0.04)
 3.59 
(0.13)
2NEO NeoGenomics
272.37
 0.06 
 2.71 
 0.15 
3CSBR Champions Oncology
220.0
 0.03 
 4.47 
 0.13 
4PACB Pacific Biosciences of
197.88
 0.09 
 6.67 
 0.61 
5RGEN Repligen
154.58
 0.01 
 3.20 
 0.04 
6IQV IQVIA Holdings
103.68
(0.18)
 1.86 
(0.33)
7TECH Bio Techne Corp
74.38
 0.02 
 2.38 
 0.06 
8AVTR Avantor
72.98
(0.21)
 1.50 
(0.31)
9BRKR Bruker
67.1
(0.07)
 2.69 
(0.19)
10SHC Sotera Health Co
61.32
(0.09)
 2.45 
(0.23)
11ILMN Illumina
49.12
 0.08 
 2.30 
 0.18 
12MEDP Medpace Holdings
49.07
(0.01)
 2.94 
(0.03)
13WAT Waters
40.43
 0.07 
 2.97 
 0.21 
14AZTA Azenta Inc
38.92
(0.02)
 2.62 
(0.05)
15MTD Mettler Toledo International
38.4
(0.11)
 1.97 
(0.21)
16A Agilent Technologies
37.55
(0.02)
 1.67 
(0.04)
17ICLR ICON PLC
33.93
(0.17)
 3.47 
(0.59)
18CRL Charles River Laboratories
33.74
 0.02 
 2.61 
 0.05 
19TMO Thermo Fisher Scientific
30.99
(0.21)
 1.23 
(0.25)
20NOTV Inotiv Inc
30.91
 0.23 
 7.10 
 1.61 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit. Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.